Literature DB >> 23470148

Secular trends in the national and provincial births of new thalassemia cases in Iran from 2001 to 2006.

Mahmoud Hadipour Dehshal1, Alireza Ahmadvand, Sakineh Yousefi Darestani, Mohsen Manshadi, Hassan Abolghasemi.   

Abstract

Thalassemia is one of the genetic diseases for which there are only a few successful prevention protocols. In this study, we aimed to analyze data for thalassemia newborns in a period of 6 years to find out the geographical distribution of cases, the "high-risk" provinces in Iran, the causes of thalassemia newborn cases, the coverage rate of the prevention programs and the limitations of the thalassemia registration system. To further our aim, an analytic cross-sectional study was designed at the Iranian Blood Transfusion Organization (IBTO), Tehran, Iran. A questionnaire was then prepared to gather data from each of the 30 provincial centers to find out the number and causes of thalassemia births. Furthermore, another questionnaire, to be completed by the physicians in charge, was aimed at gathering data from all 207 thalassemia care centers. We then performed a stratified analysis of the frequency of distributions; the associations among the existing variables were evaluated using the χ(2) or Fisher's exact tests at a 5.0% significance level. According to the findings, from 2001-2006, a total of 2091 thalassemia patients were born. The main causes were: the at-risk couples not using prenatal diagnosis (PND), marriages before the commencement of Iranian prevention plans, unregistered marriages based on religious conventions, among foreign citizens and the existence of some test errors. The causes of birth for 284 (13.6%) of new cases were not documented. There was a statistically significant difference between the five high-risk provinces regarding the proportional causes of thalassemia newborns [Pearson χ(2) = 4.549; degree of freedom (df) = 8, p value = 0.0001]. Although the plan succeeded in avoiding the annual birth of 826 new cases on average, there is continuing concern that more than 300 new cases were born every year during 2001-2006 and new prevention strategies need to be put into practice. It is highly recommended that focus be put on factors persistently causing the birth of new cases, especially in high-risk areas in which the success rates are lower than 50.0%.

Entities:  

Mesh:

Year:  2013        PMID: 23470148     DOI: 10.3109/03630269.2013.772062

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  7 in total

1.  Survival analysis and its associated factors of Beta thalassemia major in hamadan province.

Authors:  Reza Zamani; Salman Khazaei; Shahab Rezaeian
Journal:  Iran J Med Sci       Date:  2015-05

Review 2.  The Iran Thalassemia Prevention Program: Success or Failure?

Authors:  M Hashemieh; H Timori Naghadeh; M Tabrizi Namini; H Neamatzadeh; M Hadipour Dehshal
Journal:  Iran J Ped Hematol Oncol       Date:  2015-07-20

3.  Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study.

Authors:  Jafar Hassanzadeh; Alireza Mirahmadizadeh; Mehran Karimi; Yousef Veisani; Shahab Rezaeian
Journal:  J Public Health Res       Date:  2017-12-13

4.  Survival analysis of thalassemia major patients using Cox, Gompertz proportional hazard and Weibull accelerated failure time models.

Authors:  Enayatollah Bakhshi; Reza Ali Akbari Khoei; Azita Azarkeivan; Maryam Kooshesh; Akbar Biglarian
Journal:  Med J Islam Repub Iran       Date:  2017-12-17

5.  P.Gly61Glu and P.Arg368His Mutations in CYP1B1 that Cause Congenital Glaucoma may be Relatively Frequent in Certain Regions of Gilan Province, Iran.

Authors:  Mansoure Qashqai; Fatemeh Suri; Mehdi Yaseri; Elahe Elahi
Journal:  J Ophthalmic Vis Res       Date:  2018 Oct-Dec

6.  Carrier Status for p.Gly61Glu and p.Arg368His CYP1B1 Mutations Causing Primary Congenital Glaucoma in Iran.

Authors:  Ali Heshmati; Peyman Taghizadeh; Hamid Ahmadieh; Mehdi Yaseri; Fatemeh Suri; Mahsa Alizadeh; Marjan Dadashzadeh; Hajar Khatami; Monireh Moradkhah Navi; Parisa Zamanparvar; Hassan Behboudi; Elahe Elahi
Journal:  J Ophthalmic Vis Res       Date:  2021-10-25

7.  Analysis of survival data in thalassemia patients in Shiraz, Iran.

Authors:  Abdolreza Rajaeefard; Mahmoud Hajipour; Hamid Reza Tabatabaee; Jafar Hassanzadeh; Shahab Rezaeian; Zahra Moradi; Mehdi Sharafi; Mohsen Shafiee; Ali Semati; Sanaz Safaei; Maryam Soltani
Journal:  Epidemiol Health       Date:  2015-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.